Page 11 - Macromolecular Crystallography
P. 11

x  CONTRIBUTORS

        R. J. Morris, John Innes Centre, Norwich Research  Kings College London, UK.
          Park, Colney, Norwich NR4 7UH, UK.          mark.sanderson@kcl.ac.uk
          Richard.Morris@bbsrc.ac.uk                 J. V. Skelly, School of Chemical and Life Sciences,
        H. M. K. Murthy, Center for Biophysical Sciences  University of Greenwich, Central Avenue,
          and Engineering University of Alabama at     Chatham Maritime, Kent, ME4 4TB UK.
          Birmingham, CBSE 100, 1530, 3rd Ave. South,  jvskelly@yahoo.com
          Birmingham, AL 35294–4400, USA.            D. W. Smith, SGX Pharmaceuticals, Inc., 10505
          murthy@cbse.uab.edu                          Roselle Ave., San Diego, CA 92121 and
        S. Ness, Biophysical Structural Chemistry, Leiden  9700 S. Cass Ave., Building 438, Argonne,
          Institute of Chemistry, Einsteinweg 55,     IL 60439,USA.
          2333 CC Leiden, The Netherlands.            David_smith@sgxpharma.com
          sness@sness.net                            M. K. Sohi, Randall Division of Cell and
        J. E. Nettleship, The Protein Production Facility,  Molecular Biophysics, New Hunt’s House,
          Henry Wellcome Building of Genome            Guy’s Campus, Kings College London,
          Medicine, University of Oxford, UK.         SE1 1UL, UK.
          joanne@strubi.ox.ac.uk                      maninder.sohi@kcl.ac.uk
        R. J. Owens, The Protein Production Facility,  D. K. Stammers, Division of Structural Biology,
          Henry Wellcome Building of Genome            Henry Wellcome Building of Genome
          Medicine, University of Oxford, UK.          Medicine, University of Oxford, UK.
          ray@strubi.ox.ac.uk                         daves@strubi.ox.ac.uk
        N. S. Pannu, Biophysical Structural Chemistry,  D. I. Stuart, Division of Structural Biology, Henry
          Leiden Institute of Chemistry, Einsteinweg 55,  Wellcome Building of Genome Medicine,
          2333 CC Leiden, The Netherlands.             University of Oxford, UK.
          raj@chem.leidenuniv.nl                      dave@strubi.ox.ac.uk
        A. Perrakis, Netherlands Cancer Institute,   S. R. Wasserman, SGX Pharmaceuticals, Inc.,
          Department of Molecular Carcinogenesis,      10505 Roselle Ave., San Diego, CA 92121 and
          Plesmanlaan 21, 1066 CX,                     9700 S. Cass Ave., Building 438,
          Amsterdam, Netherlands.                     Argonne, IL 60439, USA.
          a.perrakis@nki.nl                           Stephen_wasserman@sgxpharma.com
        J. S. Plaisier, Biophysical Structural Chemistry,  C. M. Weeks, Hauptman-Woodward Medical
          Leiden Institute of Chemistry, Einsteinweg 55,  Research Institute, Inc., 700 Ellicott Street,
          2333 CC Leiden, The Netherlands.             Buffalo, NY 14203–1102, USA.
          plaisier@chem.leidenuniv.nl                 weeks@hwi.buffalo.edu
        Sarah Sainsbury, The Oxford Protein Facility,  A. Werner, IBMC-CNRS-ULP, UPR9002,
          Henry Wellcome Building for Genomic         15 rue René Descartes,
          Medicine, University of Oxford,             67084 Strasbourg, France.
          UK OX3 7BN                                 E. Westhof, IBMC-CNRS-ULP, UPR9002,
          sarah@strubi.ox.ac.uk                       15 rue René Descartes,
        M. R. Sanderson, Randall Division of Cell     67084 Strasbourg, France.
          and Molecular Biophysics,                   e.westhof@ibmc.u-strasbg.fr
   6   7   8   9   10   11   12   13   14   15   16